Natera News and Activities

Presence

Natera develops and provides genetic testing services for cancer care, women's health, and organ health. Its products help doctors, hospitals, and patients make screening, diagnosis, and treatment monitoring decisions.

Natera products and services overview:

Prenatal screening
Cancer testing
Organ transplant monitoring
Carrier screening
Women's health tests
Molecular diagnostics

Revenue: ~$2 billion

Employees: 4,000

Headquarters: Austin, United States (USA)

Natera is owned by Quest Diagnostics.

Quest Diagnostics is one of the...

Quest Diagnostics is a company listed under the stock ticker DGX (US).

Quest Diagnostics has a direct presence in 4 countries.

Quest Diagnostics has 6 subsidiaries including Centogene, Foresight Diagnostics and Haystack Oncology.

They are in:

Biotechnology57%
Healthcare43%

Acquisition, funding and merger involving Quest Diagnostics.

Natera has announced the acquisition of Foresight Diagnostics (posted on December 5 2025).

Executives

View the org chart displaying its 66 main executives

Most searched biographies at Natera

Popular executive movements at Natera

Eric Rubin has joined the company as Director (posted on June 3 2026).
Michael Olympios, Medical Director, Heart Transplant, has left the company (posted on June 3 2026).
Thomas Lynch has joined the company as Director (posted on June 3 2026).

Popular executive movements at Quest Diagnostics

Timothy Wentworth has joined the company as Director (posted on March 13 2026).
Benjamin Beauvalot has joined the company as Senior Vice President, Chief Strategy and Mergers and Acquisitions Officer (posted on February 26 2026).

Create your alert
to follow the executive moves at Natera.